Skip to content
healthcare.dev

Neuro-Chord

NDC 64578-0180, Homeopathic Liquid, liquid, from Energetix Corporation.

Product NDC
64578-0180
Status
Listed
Labeler
Energetix Corporation
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64578-0180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GELSEMIUM SEMPERVIRENS ROOT30 [hp_X]/59.1mL
  • SUS SCROFA ADRENAL GLAND9 [hp_X]/59.1mL
  • LATRODECTUS MACTANS30 [hp_X]/59.1mL
  • NAJA NAJA VENOM30 [hp_X]/59.1mL
  • PHOSPHORUS12 [hp_X]/59.1mL
  • LEAD15 [hp_X]/59.1mL
  • PYRIDOXINE HYDROCHLORIDE12 [hp_X]/59.1mL
  • TOXICODENDRON PUBESCENS LEAF12 [hp_X]/59.1mL
  • RIBOFLAVIN12 [hp_X]/59.1mL
  • SARSAPARILLA6 [hp_X]/59.1mL
  • THIAMINE HYDROCHLORIDE12 [hp_X]/59.1mL
  • ZINC15 [hp_X]/59.1mL
  • AMANITA MUSCARIA FRUITING BODY12 [hp_X]/59.1mL
  • ALUMINUM15 [hp_X]/59.1mL
  • ARSENIC15 [hp_X]/59.1mL
  • CADMIUM15 [hp_X]/59.1mL
  • COENZYME A12 [hp_X]/59.1mL
  • CONIUM MACULATUM FLOWERING TOP12 [hp_X]/59.1mL
  • COPPER15 [hp_X]/59.1mL

Pharmacologic classes

Analogs/Derivatives [Chemical/Ingredient]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Inhibit Ovum Fertilization [PE]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]

Package NDCNDC-11Package
64578-0180-16457801800159.1 mL in 1 BOTTLE, DROPPER (64578-0180-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 64578-0180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64578-0180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64578-0180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.